Overt Thyroid Dysfunction and Anti-Thyroid Antibodies Predict Response to Anti-PD-1 Immunotherapy in Cancer Patients-Reference-Cited by-同舟云学术

Overt Thyroid Dysfunction and Anti-Thyroid Antibodies Predict Response to Anti-PD-1 Immunotherapy in Cancer Patients

Published:2020-07-01 Issue:7 Volume:30 Page:966-973
ISSN:1050-7256
Container-title:Thyroid
language:en
Short-container-title:Thyroid

Author:

Basak Edwin A.¹,van der Meer Jan W.M.¹,Hurkmans Daan P.¹²,Schreurs Marco W.J.³,Oomen-de Hoop Esther¹,van der Veldt Astrid A.M.¹⁴,Bins Sander¹,Joosse Arjen¹,Koolen Stijn L.W.¹⁵,Debets Reno¹,Peeters Robin P.⁶,Aerts Joachim G.J.V.²,Mathijssen Ron H.J.¹,Medici Marco⁶⁷

Affiliation:

1. Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.

2. Department of Pulmonology, Erasmus University Medical Center, Rotterdam, The Netherlands.

3. Department of Immunology, Erasmus University Medical Center, Rotterdam, The Netherlands.

4. Department of Radiology and Nuclear Medicine, and Erasmus University Medical Center, Rotterdam, The Netherlands.

5. Department of Hospital Pharmacy, Erasmus University Medical Center, Rotterdam, The Netherlands.

6. Department of Internal Medicine and Erasmus MC Academic Center for Thyroid Diseases, Erasmus University Medical Center, Rotterdam, The Netherlands.

7. Department of Internal Medicine, Radboud University Medical Center, Nijmegen, The Netherlands.

Publisher

Mary Ann Liebert Inc

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://www.liebertpub.com/doi/pdf/10.1089/thy.2019.0726

Reference27 articles.

1. Management of immune checkpoint blockade dysimmune toxicities: a collaborative position paper

3. Endocrine side effects of cancer immunotherapy

4. Thyroid dysfunctions secondary to cancer immunotherapy

5. Cancer immunotherapy — immune checkpoint blockade and associated endocrinopathies

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunotherapy-Related Hypothyroidism: Mechanisms and Management;Hypothyroidism - Causes, Screening and Therapeutic Approaches [Working Title];2024-05-28

2. Association of preexisting anti-thyroid antibodies and body mass index with prognosis of lung cancer patients treated with PD-1/PD-L1 inhibitors;Oncologie;2024-04-30

3. Research hot spots and trends in endocrine-related adverse events caused by immune checkpoint inhibitors: a bibliometric analysis and visualization research;Frontiers in Endocrinology;2024-04-15

4. Thyroid dysfunction (TD) induced by PD-1/PD-L1 inhibitors in advanced lung cancer;Heliyon;2024-03

5. Knowledge domains and emerging trends in immune-related adverse events from immune checkpoint inhibitors: A bibliometrics and visualized analysis;Heliyon;2024-03